Cuz if not - there’s a big difference between screened “healthy volunteers” and general population.
Working from memory here.
Phase I trials usually feature a small number of healthy volunteers and are basically testing survivability and which dose level to use. MOderna phase I trials started March of 2020.
MOderna had low dose (15) higher dose (15) and no dose (15). There were actually 1 or two extra people that did not complete the Phase I trial so I think the end count was 45 people total.
In Moderna, there aren’t repeats.
Phase I had healthy volunteers, no elderly, and I believe that trial started in March and lasted for about 57 days.
Phase II trials looked sketchy to me. I couldn’t find it in Moderna documentation and a troll threw some information at me which, when I read it was around 600 people. Too few people and too brief to ‘count’ as a Phase II trial compared with traditional phase II trials. They are just phoning it in. I think elderly were separated into a different group but the reporting I tried to read was so different than reporting on other groups I didn’t learn much.
Phase III had variation in reported number of participants and included specific co-morbidities but ruled out others (HIV etc.). None tested pregnant women. The trial size numbers numbers were always different in the MSM - I read 50K, 45K 40K and finally 36K.
Pfizer is obscuring their trials by claiming to blend (possibly your repeat scenario?) them so I read about Phase I/II trials and references to the Phase I/II/III Trial(s) or Phase II/III so they may have some repeats, but I don’t really trust them. Pfizer’s Phase I/II/III trial ends either at the end of 2021 or 2023 - I’ve seen both reported.
Truth.